Search
Returning search results with filters:
Remove filter for
Issue: Health products
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 196 - 210 of 298 items.
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
AlertHealth professional risk communication | 2019-12-02
Unauthorized products may pose serious health risks (October 2, 2019 to November 19, 2019)
AlertPublic advisory | 2019-11-19
ULORIC ® (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes
AlertHealth professional risk communication | 2019-11-04
Unauthorized soft-shelled hyperbaric chambers may pose serious health risks
AlertInformation update | 2019-10-25
Foreign Product Alert: 24 foreign health products found to contain undeclared drug ingredients
AlertForeign product alert | 2019-10-18
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
AlertHealth professional risk communication | 2019-10-15
Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
AlertHealth professional risk communication | 2019-10-09
Unauthorized Nabota botulinum toxin may pose serious health risks
AlertPublic advisory | 2019-09-30
Unauthorized products may pose serious health risks (August 12, 2019 to September 18, 2019)
AlertPublic advisory | 2019-09-18
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17
Needle-free dermal filler devices used for cosmetic skin treatments are not authorized in Canada and may pose health risks
AlertInformation update | 2019-09-13